ELSE NUTRITION GRANTED VOLUNTARY MANAGEMENT CEASE TRADE ORDER
Else Nutrition Holdings (TSX: BABY) (OTCQX: BABYF) has been granted a voluntary management cease trade order by the British Columbia Securities Commission. The company is unable to file its annual financial statements, MD&A, and AIF for the year ended December 31, 2024, within the required 90-day period due to timing constraints in completing audit procedures.
The company expects to file these documents by April 9, 2025, and no later than May 30, 2025. During this period, the company will issue bi-weekly default status reports. The cease trade order specifically prohibits the CEO and CFO from trading company securities but does not affect other persons' ability to trade. The company confirms it is not subject to any insolvency proceedings.
Else Nutrition Holdings (TSX: BABY) (OTCQX: BABYF) ha ricevuto un ordine di cessazione volontaria delle negoziazioni dalla British Columbia Securities Commission. L'azienda non è in grado di presentare i propri bilanci annuali, il MD&A e l'AIF per l'anno conclusosi il 31 dicembre 2024, entro il periodo richiesto di 90 giorni a causa di vincoli temporali nel completamento delle procedure di audit.
L'azienda prevede di presentare questi documenti entro il 9 aprile 2025, e non oltre il 30 maggio 2025. Durante questo periodo, l'azienda emetterà rapporti sullo stato di default ogni due settimane. L'ordine di cessazione delle negoziazioni vieta specificamente al CEO e al CFO di negoziare titoli dell'azienda, ma non influisce sulla capacità di altre persone di negoziare. L'azienda conferma di non essere soggetta a procedimenti di insolvenza.
Else Nutrition Holdings (TSX: BABY) (OTCQX: BABYF) ha sido otorgada una orden de cese de negociación voluntaria por parte de la Comisión de Valores de Columbia Británica. La empresa no puede presentar sus estados financieros anuales, el MD&A y el AIF para el año que terminó el 31 de diciembre de 2024, dentro del período requerido de 90 días debido a limitaciones de tiempo en la finalización de los procedimientos de auditoría.
La empresa espera presentar estos documentos para el 9 de abril de 2025, y a más tardar el 30 de mayo de 2025. Durante este período, la empresa emitirá informes de estado de incumplimiento cada dos semanas. La orden de cese de negociación prohíbe específicamente al CEO y al CFO negociar valores de la empresa, pero no afecta la capacidad de otras personas para negociar. La empresa confirma que no está sujeta a ningún procedimiento de insolvencia.
Else Nutrition Holdings (TSX: BABY) (OTCQX: BABYF)는 브리티시컬럼비아 증권위원회로부터 자발적 거래 중지 명령을 받았습니다. 이 회사는 2024년 12월 31일에 종료된 연간 재무제표, MD&A 및 AIF를 요구되는 90일 이내에 제출할 수 없으며, 이는 감사 절차 완료에 대한 시간 제약 때문입니다.
회사는 이 문서를 2025년 4월 9일까지 제출할 예정이며, 늦어도 2025년 5월 30일까지 제출할 것입니다. 이 기간 동안 회사는 격주로 기본 상태 보고서를 발행할 것입니다. 거래 중지 명령은 CEO와 CFO가 회사 증권을 거래하는 것을 특별히 금지하지만, 다른 사람들의 거래 능력에는 영향을 미치지 않습니다. 회사는 어떠한 파산 절차에도 처해 있지 않다고 확인합니다.
Else Nutrition Holdings (TSX: BABY) (OTCQX: BABYF) a reçu un ordre de cessation volontaire de négociation de la part de la Commission des valeurs mobilières de la Colombie-Britannique. L'entreprise n'est pas en mesure de déposer ses états financiers annuels, son MD&A et son AIF pour l'exercice clos le 31 décembre 2024, dans le délai requis de 90 jours en raison de contraintes de temps liées à l'achèvement des procédures d'audit.
L'entreprise prévoit de déposer ces documents d'ici le 9 avril 2025, et au plus tard le 30 mai 2025. Pendant cette période, l'entreprise publiera des rapports d'état de défaut toutes les deux semaines. L'ordre de cessation de négociation interdit spécifiquement au PDG et au directeur financier de négocier des titres de l'entreprise, mais n'affecte pas la capacité d'autres personnes à négocier. L'entreprise confirme qu'elle n'est pas soumise à des procédures d'insolvabilité.
Else Nutrition Holdings (TSX: BABY) (OTCQX: BABYF) hat von der British Columbia Securities Commission eine freiwillige Handelsstopp-Anordnung erhalten. Das Unternehmen kann seine Jahresabschlüsse, den MD&A und das AIF für das am 31. Dezember 2024 endende Jahr aufgrund zeitlicher Einschränkungen bei der Durchführung der Prüfungsverfahren nicht innerhalb des erforderlichen Zeitraums von 90 Tagen einreichen.
Das Unternehmen erwartet, diese Dokumente bis zum 9. April 2025 und spätestens bis zum 30. Mai 2025 einzureichen. In diesem Zeitraum wird das Unternehmen alle zwei Wochen Berichte über den Status des Ausfalls veröffentlichen. Die Handelsstopp-Anordnung verbietet es dem CEO und CFO, Unternehmenswerte zu handeln, hat jedoch keinen Einfluss auf die Handelsmöglichkeiten anderer Personen. Das Unternehmen bestätigt, dass es nicht Gegenstand von Insolvenzverfahren ist.
- None.
- Delay in filing annual financial statements, MD&A, and AIF beyond regulatory deadline
- Implementation of management cease trade order restricting CEO and CFO trading
- Audit completion issues indicating potential internal control or reporting challenges
The Company concluded that it would not be in a position to complete the year-end audit within the time periods required by National Instrument 51-102 due to timing constraints in completing audit procedures. As a result, the Company requires additional time to file its annual financial statements, MD&A and AIF for the financial year ended December 31, 2024.
The Company expects to file its annual financial statements, MD&A and AIF for the year ended December 31, 2024 by April 9, 2025 and in any event no later than May 30, 2025, and will issue a news release once they have been filed. The Company intends to satisfy the provisions of the alternative information guidelines of National Policy 12-203, by issuing bi-weekly default status reports, in the form of news releases, until the revocation of the management cease trade order. The Company is not subject to any insolvency proceedings. The management cease trade order will prohibit the chief executive officer and the chief financial officer of the Company from trading in securities of the Company for so long as the annual financial statements, MD&A and AIF are not filed. The issuance of the management cease trade order does not affect the ability of persons other than the chief executive officer and the chief financial officer of the Company to trade in the Company's securities.
About Else Nutrition Holdings Inc.
Else Nutrition Holdings Inc. is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth.
Awards and Recognition:
- "2017 Best Health and Diet Solutions" award at
Milan 's Global Food Innovation Summit - #1 Best Seller on Amazon in the Fall of 2020 in the New Baby & Toddler Formula Category
- "Best Dairy Alternative" Award 2021 at World Plant-Based Expo
- Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle category
- During September 2022, Else Super Cereal reached the #1 Best Seller in Baby Cereal across all brands on Amazon
For more information, visit www.elsenutrition.com or @elsenutrition on Facebook and Instagram.
Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute "forward-looking statements" within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as "will" or similar expressions. Forward-looking statements in this press release include but are not limited to, statements with respect to the Company filing its annual financial statements, MD&A and AIF. These forward-looking statements are made as of the date of this press release. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management's perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. Although the Company believes the forward-looking statements in this press release are reasonable, it can give no assurance that the expectations and assumptions in such statements will prove to be correct. The Company cautions investors that any forward-looking statements by the Company are not guarantees of future results or performance, and are subject to risks, uncertainties, assumptions and other factors which could cause events or outcomes to differ materially from those expressed or implied by such forward-looking statements. Such factors and assumptions include, among others, variations in market conditions; currency exchange rates; the Company's ability to obtain any necessary permits, consents or authorizations required for its activities; the Company's ability to access further funding, to continue its projected growth, or to be fully able to implement its business strategies. In addition, there are known and unknown risk factors which could cause our actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management's expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
View original content to download multimedia:https://www.prnewswire.com/news-releases/else-nutrition-granted-voluntary-management-cease-trade-order-302417694.html
SOURCE Else Nutrition Holdings Inc.
FAQ
When will Else Nutrition (BABYF) file its delayed 2024 annual financial statements?
What trading restrictions does the cease trade order impose on Else Nutrition (BABYF)?
Why did Else Nutrition (BABYF) request a voluntary management cease trade order?
How will Else Nutrition (BABYF) keep investors informed during the cease trade period?
